Skip to main content
Fig. 4 | Trials

Fig. 4

From: Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Fig. 4

Flow of informed consent procedure in the MR CLEAN-MED. Abbreviations: MR CLEAN-MED, multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both or neither; ED, emergency department; EVT, endovascular treatment; ASA, intravenous acetylsalicylic acid; UFH, intravenous unfractionated heparin. Captions: *The patient or representative will be asked to provide consent as early as deemed appropriate and reasonable after hospital admission, ideally before upcoming study procedures after EVT and ultimately before final outcome assessment

Back to article page

Trials

ISSN: 1745-6215